ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Small Interfering RNA (siRNA) Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-21H15510
Home | Market Reports | Science| Biological Sciences
Global Small Interfering RNA siRNA Market Research Report 2023
BUY CHAPTERS

Global Small Interfering RNA (siRNA) Market Research Report 2025

Code: QYRE-Auto-21H15510
Report
May 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Agilent Technologies
Merck KGaA
QIAGEN (Exiqon)
Dharmacon (Horizon Discovery Group)
Synlogic
GeneCopoeia
New England Biolabs
Quantabio
BioGenex
SeqMatic LLC
NanoString Technologies, Inc.

Small Interfering RNA (siRNA) Market

The global market for Small Interfering RNA (siRNA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Small interfering RNA (siRNA) is a kind of endogenous single stranded RNA with regulatory function found in Eukaryote, generally 18-25nt. It can cause the degradation of target mRNA and inhibit its translation through specific binding with target mRNA, so as to regulate the post transcriptional expression of genes. Recent studies have shown that miRNAs are involved in various regulatory pathways, including development, viral defense, hematopoietic processes, organ formation, cell proliferation and apoptosis, and fat metabolism. DIA-UP"s advanced chemical synthesis technology can provide customers with products such as miRNA inhibitors, miRNA mimetics, miRNA negative controls, Agomir, and Antagonir.
North American market for Small Interfering RNA (siRNA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Small Interfering RNA (siRNA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Small Interfering RNA (siRNA) in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Small Interfering RNA (siRNA) include Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString Technologies, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Interfering RNA (siRNA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Interfering RNA (siRNA).
The Small Interfering RNA (siRNA) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Interfering RNA (siRNA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Interfering RNA (siRNA) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Small Interfering RNA (siRNA) Market Report

Report Metric Details
Report Name Small Interfering RNA (siRNA) Market
Segment by Type
Segment by Application
  • Cancer
  • Infectious Diseases
  • Immunological Disorder
  • Cardiovascular Disease
  • Neurological Disease
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs, Quantabio, BioGenex, SeqMatic LLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Small Interfering RNA (siRNA) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Small Interfering RNA (siRNA) Market report?

Ans: The main players in the Small Interfering RNA (siRNA) Market are Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs, Quantabio, BioGenex, SeqMatic LLC

What are the Application segmentation covered in the Small Interfering RNA (siRNA) Market report?

Ans: The Applications covered in the Small Interfering RNA (siRNA) Market report are Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, Others

What are the Type segmentation covered in the Small Interfering RNA (siRNA) Market report?

Ans: The Types covered in the Small Interfering RNA (siRNA) Market report are General Chemical Synthesis of siRNA, Sterol Modified Chemical Synthesis of siRNA

Recommended Reports

RNA Therapeutics

miRNA Products

RNA Analysis

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Interfering RNA (siRNA) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 General Chemical Synthesis of siRNA
1.2.3 Sterol Modified Chemical Synthesis of siRNA
1.3 Market by Application
1.3.1 Global Small Interfering RNA (siRNA) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Infectious Diseases
1.3.4 Immunological Disorder
1.3.5 Cardiovascular Disease
1.3.6 Neurological Disease
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Interfering RNA (siRNA) Market Perspective (2020-2031)
2.2 Global Small Interfering RNA (siRNA) Growth Trends by Region
2.2.1 Global Small Interfering RNA (siRNA) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Interfering RNA (siRNA) Historic Market Size by Region (2020-2025)
2.2.3 Small Interfering RNA (siRNA) Forecasted Market Size by Region (2026-2031)
2.3 Small Interfering RNA (siRNA) Market Dynamics
2.3.1 Small Interfering RNA (siRNA) Industry Trends
2.3.2 Small Interfering RNA (siRNA) Market Drivers
2.3.3 Small Interfering RNA (siRNA) Market Challenges
2.3.4 Small Interfering RNA (siRNA) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Interfering RNA (siRNA) Players by Revenue
3.1.1 Global Top Small Interfering RNA (siRNA) Players by Revenue (2020-2025)
3.1.2 Global Small Interfering RNA (siRNA) Revenue Market Share by Players (2020-2025)
3.2 Global Small Interfering RNA (siRNA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Interfering RNA (siRNA) Revenue
3.4 Global Small Interfering RNA (siRNA) Market Concentration Ratio
3.4.1 Global Small Interfering RNA (siRNA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Interfering RNA (siRNA) Revenue in 2024
3.5 Global Key Players of Small Interfering RNA (siRNA) Head office and Area Served
3.6 Global Key Players of Small Interfering RNA (siRNA), Product and Application
3.7 Global Key Players of Small Interfering RNA (siRNA), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Interfering RNA (siRNA) Breakdown Data by Type
4.1 Global Small Interfering RNA (siRNA) Historic Market Size by Type (2020-2025)
4.2 Global Small Interfering RNA (siRNA) Forecasted Market Size by Type (2026-2031)
5 Small Interfering RNA (siRNA) Breakdown Data by Application
5.1 Global Small Interfering RNA (siRNA) Historic Market Size by Application (2020-2025)
5.2 Global Small Interfering RNA (siRNA) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Interfering RNA (siRNA) Market Size (2020-2031)
6.2 North America Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
6.4 North America Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Interfering RNA (siRNA) Market Size (2020-2031)
7.2 Europe Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
7.4 Europe Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Interfering RNA (siRNA) Market Size (2020-2031)
8.2 Asia-Pacific Small Interfering RNA (siRNA) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Interfering RNA (siRNA) Market Size (2020-2031)
9.2 Latin America Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
9.4 Latin America Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Interfering RNA (siRNA) Market Size (2020-2031)
10.2 Middle East & Africa Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Small Interfering RNA (siRNA) Introduction
11.1.4 Agilent Technologies Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.1.5 Agilent Technologies Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Small Interfering RNA (siRNA) Introduction
11.2.4 Merck KGaA Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.2.5 Merck KGaA Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Details
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Small Interfering RNA (siRNA) Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 NanoString Technologies, Inc.
11.4.1 NanoString Technologies, Inc. Company Details
11.4.2 NanoString Technologies, Inc. Business Overview
11.4.3 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Introduction
11.4.4 NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.4.5 NanoString Technologies, Inc. Recent Development
11.5 Dharmacon (Horizon Discovery Group)
11.5.1 Dharmacon (Horizon Discovery Group) Company Details
11.5.2 Dharmacon (Horizon Discovery Group) Business Overview
11.5.3 Dharmacon (Horizon Discovery Group) Small Interfering RNA (siRNA) Introduction
11.5.4 Dharmacon (Horizon Discovery Group) Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.5.5 Dharmacon (Horizon Discovery Group) Recent Development
11.6 Synlogic
11.6.1 Synlogic Company Details
11.6.2 Synlogic Business Overview
11.6.3 Synlogic Small Interfering RNA (siRNA) Introduction
11.6.4 Synlogic Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.6.5 Synlogic Recent Development
11.7 GeneCopoeia, Inc.
11.7.1 GeneCopoeia, Inc. Company Details
11.7.2 GeneCopoeia, Inc. Business Overview
11.7.3 GeneCopoeia, Inc. Small Interfering RNA (siRNA) Introduction
11.7.4 GeneCopoeia, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.7.5 GeneCopoeia, Inc. Recent Development
11.8 New England Biolabs
11.8.1 New England Biolabs Company Details
11.8.2 New England Biolabs Business Overview
11.8.3 New England Biolabs Small Interfering RNA (siRNA) Introduction
11.8.4 New England Biolabs Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.8.5 New England Biolabs Recent Development
11.9 Quantabio
11.9.1 Quantabio Company Details
11.9.2 Quantabio Business Overview
11.9.3 Quantabio Small Interfering RNA (siRNA) Introduction
11.9.4 Quantabio Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.9.5 Quantabio Recent Development
11.10 NanoString Technologies, Inc.
11.10.1 NanoString Technologies, Inc. Company Details
11.10.2 NanoString Technologies, Inc. Business Overview
11.10.3 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Introduction
11.10.4 NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.10.5 NanoString Technologies, Inc. Recent Development
11.11 BioGenex
11.11.1 BioGenex Company Details
11.11.2 BioGenex Business Overview
11.11.3 BioGenex Small Interfering RNA (siRNA) Introduction
11.11.4 BioGenex Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.11.5 BioGenex Recent Development
11.12 SeqMatic LLC
11.12.1 SeqMatic LLC Company Details
11.12.2 SeqMatic LLC Business Overview
11.12.3 SeqMatic LLC Small Interfering RNA (siRNA) Introduction
11.12.4 SeqMatic LLC Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.12.5 SeqMatic LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Agilent Technologies
Merck KGaA
QIAGEN (Exiqon)
Dharmacon (Horizon Discovery Group)
Synlogic
GeneCopoeia
New England Biolabs
Quantabio
BioGenex
SeqMatic LLC
NanoString Technologies, Inc.
List of Tables
 Table 1. Global Small Interfering RNA (siRNA) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of General Chemical Synthesis of siRNA
 Table 3. Key Players of Sterol Modified Chemical Synthesis of siRNA
 Table 4. Global Small Interfering RNA (siRNA) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Small Interfering RNA (siRNA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Small Interfering RNA (siRNA) Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Small Interfering RNA (siRNA) Market Share by Region (2020-2025)
 Table 8. Global Small Interfering RNA (siRNA) Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Small Interfering RNA (siRNA) Market Share by Region (2026-2031)
 Table 10. Small Interfering RNA (siRNA) Market Trends
 Table 11. Small Interfering RNA (siRNA) Market Drivers
 Table 12. Small Interfering RNA (siRNA) Market Challenges
 Table 13. Small Interfering RNA (siRNA) Market Restraints
 Table 14. Global Small Interfering RNA (siRNA) Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Small Interfering RNA (siRNA) Market Share by Players (2020-2025)
 Table 16. Global Top Small Interfering RNA (siRNA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA) as of 2024)
 Table 17. Ranking of Global Top Small Interfering RNA (siRNA) Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Small Interfering RNA (siRNA) Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Small Interfering RNA (siRNA), Headquarters and Area Served
 Table 20. Global Key Players of Small Interfering RNA (siRNA), Product and Application
 Table 21. Global Key Players of Small Interfering RNA (siRNA), Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Small Interfering RNA (siRNA) Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Small Interfering RNA (siRNA) Revenue Market Share by Type (2020-2025)
 Table 25. Global Small Interfering RNA (siRNA) Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Small Interfering RNA (siRNA) Revenue Market Share by Type (2026-2031)
 Table 27. Global Small Interfering RNA (siRNA) Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Small Interfering RNA (siRNA) Revenue Market Share by Application (2020-2025)
 Table 29. Global Small Interfering RNA (siRNA) Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Small Interfering RNA (siRNA) Revenue Market Share by Application (2026-2031)
 Table 31. North America Small Interfering RNA (siRNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Small Interfering RNA (siRNA) Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Small Interfering RNA (siRNA) Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Small Interfering RNA (siRNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Small Interfering RNA (siRNA) Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Small Interfering RNA (siRNA) Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Small Interfering RNA (siRNA) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Small Interfering RNA (siRNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Small Interfering RNA (siRNA) Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Small Interfering RNA (siRNA) Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Small Interfering RNA (siRNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Agilent Technologies Company Details
 Table 47. Agilent Technologies Business Overview
 Table 48. Agilent Technologies Small Interfering RNA (siRNA) Product
 Table 49. Agilent Technologies Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
 Table 50. Agilent Technologies Recent Development
 Table 51. Merck KGaA Company Details
 Table 52. Merck KGaA Business Overview
 Table 53. Merck KGaA Small Interfering RNA (siRNA) Product
 Table 54. Merck KGaA Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
 Table 55. Merck KGaA Recent Development
 Table 56. QIAGEN (Exiqon) Company Details
 Table 57. QIAGEN (Exiqon) Business Overview
 Table 58. QIAGEN (Exiqon) Small Interfering RNA (siRNA) Product
 Table 59. QIAGEN (Exiqon) Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
 Table 60. QIAGEN (Exiqon) Recent Development
 Table 61. NanoString Technologies, Inc. Company Details
 Table 62. NanoString Technologies, Inc. Business Overview
 Table 63. NanoString Technologies, Inc. Small Interfering RNA (siRNA) Product
 Table 64. NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
 Table 65. NanoString Technologies, Inc. Recent Development
 Table 66. Dharmacon (Horizon Discovery Group) Company Details
 Table 67. Dharmacon (Horizon Discovery Group) Business Overview
 Table 68. Dharmacon (Horizon Discovery Group) Small Interfering RNA (siRNA) Product
 Table 69. Dharmacon (Horizon Discovery Group) Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
 Table 70. Dharmacon (Horizon Discovery Group) Recent Development
 Table 71. Synlogic Company Details
 Table 72. Synlogic Business Overview
 Table 73. Synlogic Small Interfering RNA (siRNA) Product
 Table 74. Synlogic Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
 Table 75. Synlogic Recent Development
 Table 76. GeneCopoeia, Inc. Company Details
 Table 77. GeneCopoeia, Inc. Business Overview
 Table 78. GeneCopoeia, Inc. Small Interfering RNA (siRNA) Product
 Table 79. GeneCopoeia, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
 Table 80. GeneCopoeia, Inc. Recent Development
 Table 81. New England Biolabs Company Details
 Table 82. New England Biolabs Business Overview
 Table 83. New England Biolabs Small Interfering RNA (siRNA) Product
 Table 84. New England Biolabs Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
 Table 85. New England Biolabs Recent Development
 Table 86. Quantabio Company Details
 Table 87. Quantabio Business Overview
 Table 88. Quantabio Small Interfering RNA (siRNA) Product
 Table 89. Quantabio Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
 Table 90. Quantabio Recent Development
 Table 91. NanoString Technologies, Inc. Company Details
 Table 92. NanoString Technologies, Inc. Business Overview
 Table 93. NanoString Technologies, Inc. Small Interfering RNA (siRNA) Product
 Table 94. NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
 Table 95. NanoString Technologies, Inc. Recent Development
 Table 96. BioGenex Company Details
 Table 97. BioGenex Business Overview
 Table 98. BioGenex Small Interfering RNA (siRNA) Product
 Table 99. BioGenex Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
 Table 100. BioGenex Recent Development
 Table 101. SeqMatic LLC Company Details
 Table 102. SeqMatic LLC Business Overview
 Table 103. SeqMatic LLC Small Interfering RNA (siRNA) Product
 Table 104. SeqMatic LLC Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
 Table 105. SeqMatic LLC Recent Development
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources
 Table 109. Authors List of This Report


List of Figures
 Figure 1. Small Interfering RNA (siRNA) Picture
 Figure 2. Global Small Interfering RNA (siRNA) Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Small Interfering RNA (siRNA) Market Share by Type: 2024 VS 2031
 Figure 4. General Chemical Synthesis of siRNA Features
 Figure 5. Sterol Modified Chemical Synthesis of siRNA Features
 Figure 6. Global Small Interfering RNA (siRNA) Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Small Interfering RNA (siRNA) Market Share by Application: 2024 VS 2031
 Figure 8. Cancer Case Studies
 Figure 9. Infectious Diseases Case Studies
 Figure 10. Immunological Disorder Case Studies
 Figure 11. Cardiovascular Disease Case Studies
 Figure 12. Neurological Disease Case Studies
 Figure 13. Others Case Studies
 Figure 14. Small Interfering RNA (siRNA) Report Years Considered
 Figure 15. Global Small Interfering RNA (siRNA) Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Small Interfering RNA (siRNA) Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Small Interfering RNA (siRNA) Market Share by Region: 2024 VS 2031
 Figure 18. Global Small Interfering RNA (siRNA) Market Share by Players in 2024
 Figure 19. Global Top Small Interfering RNA (siRNA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA) as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Small Interfering RNA (siRNA) Revenue in 2024
 Figure 21. North America Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Small Interfering RNA (siRNA) Market Share by Country (2020-2031)
 Figure 23. United States Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Small Interfering RNA (siRNA) Market Share by Country (2020-2031)
 Figure 27. Germany Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Small Interfering RNA (siRNA) Market Share by Region (2020-2031)
 Figure 35. China Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Small Interfering RNA (siRNA) Market Share by Country (2020-2031)
 Figure 43. Mexico Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Small Interfering RNA (siRNA) Market Share by Country (2020-2031)
 Figure 47. Turkey Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Agilent Technologies Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
 Figure 51. Merck KGaA Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
 Figure 52. QIAGEN (Exiqon) Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
 Figure 53. NanoString Technologies, Inc. Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
 Figure 54. Dharmacon (Horizon Discovery Group) Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
 Figure 55. Synlogic Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
 Figure 56. GeneCopoeia, Inc. Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
 Figure 57. New England Biolabs Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
 Figure 58. Quantabio Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
 Figure 59. NanoString Technologies, Inc. Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
 Figure 60. BioGenex Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
 Figure 61. SeqMatic LLC Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Small Interfering RNA siRNA Drugs Market Research Report 2024
Global Small Interfering RNA siRNA Therapeutics Market Insights Forecast to 2030
Global Small Interfering RNA siRNA based Therapeutics Market Research Report 2024
Global miRNA Tools and Services Market Research Report 2024
Global MicroRNA Market Research Report 2024
Global miRNA Microarray Kits Reagents Market Research Report 2024
Global miRNA Sequencing and Assay Market Insights Forecast to 2030
Global RNA Interference RNAi Based Therapeutics Market Research Report 2024
Global miRNA Inhibitor Market Research Report 2024
Global Small Nucleic Acid Drug Market Research Report 2025
Global RNAi for Therapeutic Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global MicroRNA Reverse Transcription Market Research Report 2024
Global Vector Based RNAi Market Research Report 2024
Global RNAi Therapeutics Market Research Report 2024
Global miRNA Clones Market Research Report 2025
Antisense and RNAi Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
RNAi Technology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global RNAi based Biopesticides Market Research Report 2024
Global Low Molecular Weight Nucleic Acid Drugs Market Research Report 2025
RNAi Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions